Artículos ADMIRABLE: Envíos recientes
Mostrando ítems 21-40 de 158
-
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
(2023-09, Springer Nature)Artículo -
Mapa epidemiológico transversal de las ataxias y paraparesias espásticas hereditarias en España
(2023-03, Elsevier)Artículo -
Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale
(2023-01, International Parkinson and Movement Disorder Society)Artículo -
-
-
-
La asistencia telefónica de las enfermedades neurológicas: una revisión sistemática
(2023-08, Viguera Editores)Artículo -
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results
(2023-07, IOS Press)Artículo -
Occupational performance in Huntington’s disease: A cross-sectional study
(2023-04, SAGE Publications)Artículo -
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
(2023-02, MDPI)Artículo -
-
Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints
(2023-01, Korean Neurological Association)Artículo -
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
(2023-02, MDPI)Artículo -
-
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden
(2023-11, Wiley)Artículo -
Cybersickness. A systematic literature review of adverse effects related to virtual reality
(2022-07, Elsevier)Artículo -
Fases en la decisión de solicitar la eutanasia y estructuras cerebrales involucradas
(2022-01, Viguera Editores)Artículo -
-
A systematic review of wearable biosensor usage in immersive virtual reality experiences
(2024-06, Springer)Artículo -
Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
(2022-04, IOS Press)Artículo